Literature DB >> 14612193

Development of an IL-6 antagonist peptide that induces apoptosis in 7TD1 cells.

Rossella Manfredini1, Elena Tenedini, Michela Siena, Enrico Tagliafico, Monica Montanari, Alexis Grande, Tommaso Zanocco-Marani, Cristina Poligani, Roberta Zini, Claudia Gemelli, Anna Bergamaschi, Tatiana Vignudelli, Francesca De Rienzo, Pier Giuseppe De Benedetti, Maria Cristina Menziani, Sergio Ferrari.   

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine involved in the regulation of proliferation and differentiation of hematopoietic cells and in the pathogenesis of many diseases, including multiple myeloma. This study pursues a way to interfere with IL-6 pathway in an attempt to modulate its biological activity. Here we describe the rational design and biological evaluation of peptides able to antagonize the murine IL-6 activity by interfering with IL-6 Receptor alpha in 7TD1 cells, a IL-6-dependent B-cell line. Of the peptide tested, only Guess 4a is capable of interfering with IL-6 transducing pathway, therefore inducing growth arrest and apoptosis of 7TD1 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14612193     DOI: 10.1016/j.peptides.2003.06.005

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

1.  Structure-based virtual screening and characterization of a novel IL-6 antagonistic compound from synthetic compound database.

Authors:  Jing Wang; Chunxia Qiao; He Xiao; Zhou Lin; Yan Li; Jiyan Zhang; Beifen Shen; Tinghuan Fu; Jiannan Feng
Journal:  Drug Des Devel Ther       Date:  2016-12-15       Impact factor: 4.162

2.  Ligand-Mediated Targeting of Cytokine Interleukin-27 Enhances Its Bioactivity In Vivo.

Authors:  Marxa L Figueiredo; Manoel Figueiredo Neto; Janelle Wes Salameh; Richard E Decker; Rachel Letteri; Delphine Chan-Seng; Todd Emrick
Journal:  Mol Ther Methods Clin Dev       Date:  2020-03-30       Impact factor: 6.698

3.  Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo.

Authors:  Sheila Ranganath; Ashok Bhandari; Nicole Avitahl-Curtis; Jaimee McMahon; Derek Wachtel; Jenny Zhang; Christopher Leitheiser; Sylvie G Bernier; Guang Liu; Tran T Tran; Herodion Celino; Jenny Tobin; Joon Jung; Hong Zhao; Katie E Glen; Chris Graul; Aliesha Griffin; Wayne C Schairer; Carolyn Higgins; Tammi L Reza; Eva Mowe; Sam Rivers; Sonya Scott; Alex Monreal; Courtney Shea; Greg Bourne; Casey Coons; Adaline Smith; Kim Tang; Ramya A Mandyam; Jaime Masferrer; David Liu; Dinesh V Patel; Angelika Fretzen; Craig A Murphy; G Todd Milne; Mark L Smythe; Kenneth E Carlson
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

4.  Interleukin-27 Gene Delivery Targeting IL-6Rα-Expressing Cells as a Stress Response Therapy.

Authors:  Manoel Figueiredo Neto; Shengzhi Liu; Janelle Wes Salameh; Hiroki Yokota; Marxa Leão Figueiredo
Journal:  Int J Mol Sci       Date:  2020-02-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.